Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. scores highest on Anchor (49) and lowest on Nitro (19). Its PosiPenta is 38.74 out of 100, weaker than most similar companies.
On the Penta Grid this week, Voyager Therapeutics, Inc. is Grid #580 of 836 in the Healthcare sector in United States, and Grid #3,002 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. | 38.74 | 43 | 39 | 19 | 44 | 49 |
| Black Diamond Therapeutics, Inc. | 35.22 | 39 | 34 | 28 | 50 | 24 |
| Unicycive Therapeutics, Inc. | 39.59 | 31 | 63 | 20 | 51 | 33 |
| Cibus, Inc. | 29.38 | 10 | 50 | 31 | 8 | 48 |
| Seer, Inc. | 53.36 | 46 | 38 | 81 | 56 | 47 |
| Minerva Neurosciences, Inc. | 34.91 | 0 | 41 | 16 | 88 | 30 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.05 |
| P/B ratio | 0.76 |
EEarnings
| Trailing EPS | ₹-171.43 |
| Forward EPS | ₹-121.14 |
NNitro
| Price | 179.96 |
| 52-week high | 519.04 |
| 52-week low | 179.01 |
| Fall from 52-week high | 65.3% |
TTorque
| Return on equity (ROE) | -54.09% |
| Debt-to-equity | 0.21 |
AAnchor
| Beta (price swings) | 1.28 |
| Market cap | ₹1,108 Cr |
| Insider holding | 14.84% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Voyager Therapeutics, Inc.'s PosiPenta score?
Voyager Therapeutics, Inc.'s PosiPenta is 38.74 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Voyager Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Voyager Therapeutics, Inc. is Grid #580 of 836 in the Healthcare sector in United States, and Grid #3,002 of 3,999 in United States.
Which PosiPenta pillar is strongest for Voyager Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 49 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Voyager Therapeutics, Inc.?
Nitro (momentum), with a score of 19 out of 100: much weaker than most similar companies.
Has Voyager Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.79 points, from 35.95 to 38.74.
PositoAI is for research and education only and is not investment advice.